TISSEEL KIT VH 2.0
TISSEEL KIT VH 2.0
Discontinued
DIN Number
02233274
Drug Class
Human
Market Date
Oct 13, 1998
Company
HC
Baxter AG
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02233274
AIG Number0936991008
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
,
Prescription
A
ATC Code
B02BD20 COMBINATIONS
Product Specifications
Dosage FormLiquid
,
Kit
,
Powder For Solution
Route of AdministrationTopical
AHFS Classification20:28.16
Health Canada Classification
ACTIVE INGREDIENTS (9)
APROTININ (BOVINE)Active
Strength: 6000 KIU / 2 ML
Monograph: APROTININ (BOVINE)
CALCIUM CHLORIDEActive
Strength: 80 MCMOL / 2 ML
Monograph: CALCIUM CHLORIDE
FACTOR XIIIActive
Strength: 100 UNIT / 2 ML
Monograph: FACTOR XIII
FIBRINOGEN (HUMAN)Active
Strength: 220 MG / 2 ML
Monograph: FIBRINOGEN (HUMAN)
PLASMAFIBRONECTIN (CIG)Active
Strength: 18 MG / 2 ML
Monograph: PLASMAFIBRONECTIN (CIG)
PLASMINOGENActive
Strength: 240 MCG / 2 ML
Monograph: PLASMINOGEN
THROMBIN (HUMAN)Active
Strength: 8 UNIT / 2 ML
Monograph: THROMBIN (HUMAN)
THROMBIN (HUMAN)Active
Strength: 1000 UNIT / 2 ML
Monograph: THROMBIN (HUMAN)
TOTAL PROTEINActive
Strength: 260 MG / 2 ML
Monograph: TOTAL PROTEIN